CRUSIA

This brand name is authorized in Austria, Ecuador, Estonia, Germany, Israel, New Zealand, Poland, Romania, South Africa.

Active ingredients

The drug CRUSIA contains one active pharmaceutical ingredient (API):

1	Enoxaparin UNII 8NZ41MIK1O - ENOXAPARIN SODIUM
	Enoxaparin is a LMWH with a mean molecular weight of approximately 4,500 daltons, in which the antithrombotic and anticoagulant activities of standard heparin have been dissociated. The drug substance is the sodium salt and has a high anti-Xa activity.
	Read more about Enoxaparin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CRUSIA Solution for injection	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AB05	Enoxaparin	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AB Heparin group
Discover more medicines within B01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	15861736, 15861742, 15861759, 15861802, 15861819, 15861854, 15861860, 15861908, 15861914
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	6713-MEE-1121, 7157-MEE-0322, 7158-MEE-0322, 7160-MEE-0322
EE	Ravimiamet	1662522, 1662533, 1662544, 1662555, 1662566, 1662577, 1745355, 1745366, 1745377, 1745388, 1745399, 1745401, 1745557, 1745568, 1745579, 1745580, 1745591, 1745603, 1745614, 1745625, 1745636, 1745647, 1745658, 1745669, 1745670, 1745681, 1745692, 1745704, 1745715, 1781995, 1782008, 1782019
IL	מִשְׂרַד הַבְּרִיאוּת	8440, 8441, 8442, 8443, 8444
NZ	Medicines and Medical Devices Safety Authority	18139, 18140
PL	Rejestru Produktów Leczniczych	100387361, 100387378, 100387390, 100387409, 100387421, 100387438, 100387444
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64541001, W64541002, W64541003, W64541004, W64541005, W64541006, W64541007, W64541008, W64541009, W64541010, W64541011, W64541012, W64541013, W64541014, W64542001, W64542002, W64542003, W64542004, W64542005, W64542006, W64542007, W64542008, W64542009, W64542010, W64542011, W64542012, W64542013, W64542014, W64543001, W64543002, W64543003, W64543004, W64543005, W64543006, W64543007, W64543008, W64543009, W64543010, W64543011, W64543012, W64543013, W64543014, W64544001, W64544002, W64544003, W64544004, W64544005, W64544006, W64544007, W64544008, W64544009, W64544010, W64544011, W64544012, W64545001, W64545002, W64545003, W64545004, W64545005, W64545006, W64545007, W64545008, W64545009, W64545010
ZA	Health Products Regulatory Authority	55/8.2/0009, 55/8.2/0010, 55/8.2/0011, 55/8.2/0012, 55/8.2/0013